MAPT and Alzheimer disease: ,139 Since the MEG recordings in our study were conducted between 2009 and 2016, the 2011 AD diagnostic criteria60 were the established and appropriate standards during that period, involving clinical and neuropsychological evaluation in addition to brain MRI but not biological biomarkers or amyloid/tau PET-scans.